NCT05017493View on ClinicalTrials.gov

Treatment of Covid-19 With a Herbal Compound, Xagrotin

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

661

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

December 7, 2020

Study Completion Date

February 8, 2021

Conditions
Covid19
Interventions
COMBINATION_PRODUCT

Xagrotin

A group of patients were treated with Xagrotin with or without standard of care, the control group received stadard of care

Trial Locations (1)

Unknown

Directorate of health of Sulaimani, Iraq -KRG, Sulaymaniyah

Sponsors

Lead Sponsor

Biomad AS
All Listed Sponsors
collaborator

Directorate of Health of Sulaimani, Iraq

OTHER

lead

Biomad AS

INDUSTRY